Showing results (31-40 of 196) with videos related to
Sort By:
Pageof 20
Anticancer Research|May 6, 2021
MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 PathwayKoji Takao, Hirotaka Konishi, Daiki Matsubara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Laparoscopic Gastrostomy for a Patient with Wernicke's Encephalopathy after Gastrectomy--A Case Report with a Literature Review]Tomohiro Arita, Shuhei Komatsu, Toshiyuki Kosuga, et al.Annals of Surgical Oncology|February 10, 2021
Amlodipine and Verapamil, Voltage-Gated Ca<sup>2+</sup> Channel Inhibitors, Suppressed the Growth of Gastric Cancer Stem CellsAtsushi Shiozaki, Keita Katsurahara, Michihiro Kudou, et al.Annals of Surgical Oncology|August 16, 2022
NADPH Oxidase 2 Has a Crucial Role in Cell Cycle Progression of Esophageal Squamous Cell CarcinomaHiroki Shimizu, Keita Katsurahara, Hiroyuki Inoue, et al.Genes|July 29, 2023
Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal TransitionJun Shibamoto, Tomohiro Arita, Hirotaka Konishi, et al.Cancer Science|December 19, 2022
Plasma microRNA-192-5p can predict the response to neoadjuvant chemotherapy and prognosis in esophageal cancerHirotaka Furuke, Hirotaka Konishi, Tomohiro Arita, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[A Useful Case of Photodynamic Diagnosis of Inferior Vena Cava Invasion by Pancreatic Head Cancer Using 5-Aminolevulinic Acid(5-ALA)]Toru Mizutani, Yasutoshi Murayama, Hisashi Ikoma, et al.World Journal of Surgery|February 4, 2021
Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon CancerHiroki Shimizu, Yoshiaki Kuriu, Tomohiro Arita, et al.Internal Medicine (Tokyo, Japan)|June 3, 2026
Trends, Demographic Characteristics, and Seasonal Patterns of Nonoperative and Operative Reduction for Intussusception: A Preliminary Nationwide Claims-Based Analysis from 2014 to 2023 in JapanMasamitsu Kido, Ken Inoue, Reo Kobayashi, et al.Journal of Gastroenterology|April 9, 2017
Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitorAtsushi Shiozaki, Michihiro Kudou, Daisuke Ichikawa, et al.Pageof 20